Blue Jet Healthcare Limited (BOM:544009)

Market Cap	130.02B
Revenue (ttm)	8.73B
Net Income (ttm)	2.35B
Shares Out	n/a
EPS (ttm)	13.54
PE Ratio	55.38
Forward PE	n/a
Dividend	1.00 (0.13%)
Ex-Dividend Date	Sep 17, 2024

Volume	45,598
Average Volume	54,526
Open	745.15
Previous Close	751.65
Day's Range	745.15 - 789.20
52-Week Range	328.95 - 844.85
Beta	n/a
RSI	55.09
Earnings Date	Feb 14, 2025

About Blue Jet Healthcare

Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related salts. It has operations in India, Norw...

• Industry: Pharmaceutical Preparations
• Founded: 1968
• Employees: 447
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544009

Financial Performance

In 2023, Blue Jet Healthcare's revenue was 7.12 billion, a decrease of -1.30% compared to the previous year's 7.21 billion. Earnings were 1.64 billion, an increase of 2.33%.